The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Founder mutations in BRCA1 and BRCA2 genes
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program
Brose, M. S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1365 · Cited by 728
Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., & Brody, L. C. (1995) · Nature Genetics · doi:10.1038/ng1095-198 · Cited by 647
Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ögmundsdottir, H. M., & Eyfjörd, J. E. (1996) · Nature Genetics · doi:10.1038/ng0596-117 · Cited by 525
Cancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
Liede, A., Karlan, B. Y., & Narod, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 407
A Review of the Diagnosis and Management of Male Breast Cancer
Giordano, S. H. (2005) · The Oncologist · doi:10.1634/theoncologist.10-7-471 · Cited by 347
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families
Simard, J., Tonin, P., Durocher, F., Morgan, K., Rommens, J., Gingras, S., Samson, C., Leblanc, J.-F., Bélanger, C., Dion, F., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-392 · Cited by 324
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer
Neuhausen, S., Gilewski, T., Norton, L., Tran, T., McGuire, P., Swensen, J., Hampel, H., Borgen, P., Brown, K., Skolnick, M., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-126 · Cited by 304
Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian Cancer
Górski, B., Byrski, T., Huzarski, T., Jakubowska, A., Menkiszak, J., Gronwald, J., Płużańska, A., Bębenek, M., Fischer-Maliszewska, Ł., Grzybowska, E., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302922 · Cited by 256
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.
Jóhannesdóttir, G., Guðmundsson, J., Bergþorsson, J. Þ., Arason, A., Agnarsson, B. A., Eiríksdóttir, G., Johannsson, O. T., Borg, Å., Ingvarsson, S., Easton, D. F., et al. (1996) · PubMed · Cited by 223
German Consortium for Hereditary Breast and Ovarian Cancer (2002) · International Journal of Cancer · doi:10.1002/ijc.1626 · Cited by 205
Inherited breast and ovarian cancer
Szabo, C., & King, M. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.suppl_1.1811 · Cited by 203
Friedman, L. S., Szabo, C. I., Ostermeyer, E. A., Dowd, P., Butler, L. M., Park, T., Lee, M. K., Goode, E. L., Rowell, S. E., & King, M. (1995) · PubMed Central · Cited by 191
Breast cancer genetics in African Americans
Olopade, O. I., Fackenthal, J. D., Dunston, G., Tainsky, M. A., Collins, F., & Whitfield-Broome, C. (2003) · Cancer · doi:10.1002/cncr.11019 · Cited by 175
The University of North Carolina at Chapel Hill University Libraries (2020) · PubMed · doi:10.17615/jkkh-v976 · Cited by 167
Founder BRCA1 and BRCA2 Mutations in French Canadian Breast and Ovarian Cancer Families
Tonin, P. N., Mes-Masson, A.-M., Futreal, P. A., Morgan, K., Mahon, M., Foulkes, W. D., Cole, D. E. C., Provencher, D., Ghadirian, P., & Narod, S. A. (1998) · The American Journal of Human Genetics · doi:10.1086/302099 · Cited by 165
BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews
Kirchhoff, T., Kauff, N. D., Mitra, N., Nafa, K., Huang, H., Palmer, C., Gulati, T., Wadsworth, E., Donat, S., Robson, M. E., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0604 · Cited by 165
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan, J. M., Boyd, J. A., Kauff, N. D., Robson, M. E., Scheuer, L., Narod, S. A., & Offit, K. (2002) · PubMed · Cited by 152
Stoppa‐Lyonnet, D., Laurent‐Puig, P., Essioux, L., Pagès-Berhouet, S., Ithier, G., Ligot, L., Fourquet, A., Salmon, R. J., Clough, K. B., Pouillart, P., et al. (1997) · Europe PMC (PubMed Central) · Cited by 141
Vega, A. I., Campos, B., Paillerets, B. B., Bond, P. M., Janin, N., Douglas, F., Domènech, M., Baena, M., Pericay, C., Alonso, C., et al. (2001) · Human Mutation · doi:10.1002/humu.1136 · Cited by 141
Antoniou, A. C., Pharoah, P. D. P., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Olsson, H. L., Johannsson, O. T., Borg, Å., Pasini, B., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024133 · Cited by 141
Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients
Rashid, M. U., Zaidi, A., Torres, D., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22269 · Cited by 122
Torres, D., Rashid, M. U., Gil, F., Umaña, Á., Ramelli, G., Robledo, J. F., Tawil, M., Torregrosa, L., Briceño, I., & Hamann, U. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9370-1 · Cited by 106
Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations
Kadouri, L., Hubert, A., Rotenberg, Y., Hamburger, T., Sagi, M., Nechushtan, C., Abeliovich, D., & Peretz, T. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.048173 · Cited by 99
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland
Sarantaus, L., Huusko, P., Eerola, H., Launonen, V., Vehmanen, P., Rapakko, K., Gillanders, E. M., Syrjäkoski, K., Kainu, T., Vahteristo, P., et al. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200529 · Cited by 97
BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines
Matsuda, M. L. D. L., Liede, A., Kwan, E., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10194 · Cited by 95
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients
Соколенко, А. П., Mitiushkina, N. V., Buslov, K. G., Бит-Сава, Е. М., Iyevleva, A. G., Преображенская, Е. В., Kuligina, E. S., Ulibina, Y. M., Rozanov, M. E., Suspitsin, E. N., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.050 · Cited by 85
Founder mutations among the Dutch
Zeegers, M. P., van Poppel, F. W. A., VLIETINCK, R. F., Spruijt, L., & D, H. O. M. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201151 · Cited by 78
Pohlreich, P., Zikán, M., Stribrna, J., Kleibl, Z., Janatová, M., Kotlas, J., Židovská, J., Novotný, J., Petruželka, L., Szabo, C., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1282 · Cited by 75
Hereditary breast cancer in Jews
Rubinstein, W. S. (2004) · Familial Cancer · doi:10.1007/s10689-004-9550-2 · Cited by 70
Khoo, U., Chan, K. Y. K., Cheung, A., Xue, W. C., Shen, D., Fung, K.-Y., Ngan, H., Choy, K. W., Pang, C. P., Poon, C. S., et al. (2002) · Human Mutation · doi:10.1002/humu.9015 · Cited by 66
Reeves, M. D., Yawitch, T. M., van der Merwe, N. C., den Berg, H. J. V., Dreyer, G., & van Rensburg, E. J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20186 · Cited by 65
Rafnar, Þ., Benediktsdóttir, K. R., Eldon, B., Gestsson, T., Saemundsson, H., Olafsson, K., Salvarsdottir, A., Steingrı́msson, E., & Thorlacius, S. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.09.008 · Cited by 62
Bergman, A., Einbeigi, Z., Olofsson, U., et al. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200704 · Cited by 58
Vézina, H., Durocher, F., Dumont, M., Houde, L., Szabo, C., Tranchant, M., Chiquette, J., Plante, M., Laframboise, R., Lépine, J., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-1297-9 · Cited by 58
Genetic alterations in hereditary breast cancer
Cipollini, G., Tommasi, S., Paradiso, A., Aretini, P., Bonatti, F., Brunetti, I. M., Bruno, M., Lombardi, G., Schittulli, F., Sensi, E., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh651 · Cited by 57
Hereditary ovarian cancer in Ashkenazi Jews
Robles-d�az, L., Goldfrank, D. J., Kauff, N. D., Robson, M. E., & Offit, K. (2004) · Familial Cancer · doi:10.1007/s10689-004-9552-0 · Cited by 46
Heimdal, K., Mæhle, L., Apold, J., Pedersen, J. C., & Møller, P. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00548-3 · Cited by 38
Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore
Lee, A. S. G., Ho, G., Oh, P. C., Balram, C., Ooi, L. L., Lim, D. T. H., Wong, C. Y., & Hong, G. S. (2003) · Human Mutation · doi:10.1002/humu.9162 · Cited by 22
Cited by
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond
Hansford, S., Kaurah, P., Li-Chang, H., Woo, M., Senz, J., Pinheiro, H., Schrader, K. A., Schaeffer, D. F., Shumansky, K., Zogopoulos, G., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2014.168 · Cited by 694
Genetics of breast cancer: a topic in evolution
Shiovitz, S., & Korde, L. A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv022 · Cited by 525
Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
Petrucelli, N., Daly, M. B., & Feldman, G. L. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181d38f2f · Cited by 339
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Rebbeck, T. R., Friebel, T. M., Friedman, E., Hamann, U., Huo, D., Kwong, A., Olah, E., Olopade, O. I., Solano, A. R., Teo, S.-H., et al. (2018) · Human Mutation · doi:10.1002/humu.23406 · Cited by 312
Metadata
- Authors
- Ferla, R., Calò, V., Cascio, S., Rinaldi, G., Badalamenti, G., Carreca, I., Surmacz, E., Colucci, G., Bazan, V., & Russo, A.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 18
- Pages
- vi93-vi98
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2101746551
- Cited by
- 286
- References
- 40
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.